Hereditary Hemorrhagic Telangiectasia: Presenting with Epistaxis. A Case Report
نویسندگان
چکیده
1 Assistant Professor, Department of Cardiac Anaesthesiology Institute of Postgraduate Medical Education & Research, Kolkata, India 2 Assistant Professor, Department of Anaesthesiology, Kishanganj Medical College, Kolkata, India 3 PDT Department of Cardiac Anaesthesiology Institute of Postgraduate Medical Education & Research, Kolkata 4 Professor Department of Anaesthesiology, N.R.S Medical College, Kolkata, India 5 Professor Department of Cardiac Anaesthesiology Institute of Postgraduate Medical Education & Research, Kolkata, India 6 Professor & Head, Department of Cardiac Anaesthesiology Institute of Postgraduate Medical Education & Research, Kolkata, India
منابع مشابه
Hereditary Hemorrhagic Telangiectasia: Presenting with Epistaxis
Osler-Weber-Rendu disease (OWRD) or Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant disorder that causes muco-cutanesous and visceral vascular dysplasia and results in increased tendency for bleeding [1-4]. Patients with HHT may present with variety of symptoms and management differs accordingly. Epistaxis is the most common symptom of HHT and mucocutaneous telangiectas...
متن کاملHereditary Hemorrhagic Telangiectasia With Liver Vascular Malformation Presenting With High-Output Heart Failure
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant genetic disease manifested by formation of telangiectasias and visceral vascular malformations of organ systems, including the skin, lungs, gastrointestinal tract, brain, and liver. Hepatic involvement may lead to portal hypertension, high-output cardiac failure, and biliary strictures.1 Diagnosis requires patients to have 3 o...
متن کاملBlessing for the bleeder: bevacizumab in hereditary hemorrhagic telangiectasia.
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder characterized by uncontrolled multisystem angiogenesis with epistaxis, gastrointestinal bleeding, iron-deficiency anemia, and arteriovenous malformations, and is often associated with increased levels of vascular endothelial growth factor (VEGF). Bevacizumab, a VEGF inhibitor, reduces epistaxis, telangiectasias, and iron-deficien...
متن کامل[Ophthalmologic diagnosis of hereditary hemorrhagic telangiectasia or Rendu-Osler-Weber disease].
CASE REPORT Our patient was a 45-year-old woman who had recurrent episodes of hematic epiphora, repeated epistaxes for which no cause was found and a family history of gastric hemorrhage. One of her daughters also suffered from spontaneous hemorrhages. DISCUSSION Hereditary hemorrhagic telangiectasia is rarely diagnosed by an ophthalmologist; however the occurrence of bloody tears occurring s...
متن کاملBevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report
CASE DESCRIPTION Five-year-old female patient with hereditary hemorrhagic telangiectasia. CLINICAL FINDINGS Deterioration of cardiopulmonary function with higher oxygen requirements secondary to pulmonary arteriovenous shunts, epistaxis. TREATMENT AND OUTCOME The patient was treated with the monoclonal antibody bevacizumab, which inhibits the vascular endothelial growth factor, with good cl...
متن کامل